Drug Product Stability: Long Term and Accelerated Stability is Just the Beginning
WEBINAR
In this webinar, you will learn:
- Guidance on Advanced Therapy Medicinal Products (ATMPs)/Cell and Gene Therapies (CGT)
- Short term and in-use storage condition requirements for drug products
- What development stages need stability data
Stability studies guide the understanding of how long and under what conditions drug substances and drug product are safe and efficacious. Long term and accelerated studies provide essential information but studies such as in-use, photostability and temperature excursion studies provide pragmatic data to guide the use of products in real world scenarios and quality control activities. These auxiliary studies require careful planning and are discussed as they apply to Advance Therapy Medicinal Products/GCT and traditional biological drug products. Recent draft guidance from both the USP and ICH have highlighted the need for these studies in successful regulatory submissions.
Speaker List

Brian Woodrow
Merck
Technical Consultant
Brian Woodrow is a technical consultant within the Scientific and Regulatory Consultancy team. He is an experienced pharmaceutical scientist with 25+ years in a Quality Control and R&D setting. Brian has an operations background leading departments covering Cell and Gene Therapy, antibody and small molecule drug substances and products.
Pharma and biopharma manufacturing
- Protein biology
Duration:45min
Language:English
Session 1:presented October 23, 2025
To continue reading please sign in or create an account.
Don't Have An Account?